Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein K Juvale, VFS Pape, M Wiese Bioorganic & medicinal chemistry 20 (1), 346-355, 2012 | 142 | 2012 |
Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2 K Juvale, K Stefan, M Wiese European journal of medicinal chemistry 67, 115-126, 2013 | 107 | 2013 |
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2) K Juvale, J Gallus, M Wiese Bioorganic & medicinal chemistry 21 (24), 7858-7873, 2013 | 106 | 2013 |
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights S Puri, K Juvale European journal of medicinal chemistry 199, 112393, 2020 | 71 | 2020 |
4-Substituted-2-phenylquinazolines as inhibitors of BCRP K Juvale, M Wiese Bioorganic & medicinal chemistry letters 22 (21), 6766-6769, 2012 | 68 | 2012 |
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2) S Kraege, K Stefan, K Juvale, T Ross, T Willmes, M Wiese European Journal of Medicinal Chemistry 117, 212-229, 2016 | 63 | 2016 |
Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2 K Silbermann, CP Shah, NU Sahu, K Juvale, SM Stefan, PS Kharkar, ... European Journal of Medicinal Chemistry 164, 193-213, 2019 | 43 | 2019 |
Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity J Gallus, K Juvale, M Wiese Biochimica et Biophysica Acta (BBA) - Biomembranes 1838 (11), 2929–2938, 2014 | 39 | 2014 |
Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation MS Singh, K Juvale, M Wiese, A Lamprecht European Journal of Pharmaceutical Sciences 77, 1-8, 2015 | 24 | 2015 |
Cancer cell fusion: A potential target to tackle drug-resistant and metastatic cancer cells C Fernandes, P Prabhu, K Juvale, D Suares, YC Mayur Drug Discovery Today 24 (9), 1836-1844, 2019 | 23 | 2019 |
Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study S Puri, I Ahmad, H Patel, K Kumar, K Juvale Toxicology in Vitro 86, 105517, 2023 | 21 | 2023 |
Inhibitors of inosine 5′-monophosphate dehydrogenase as emerging new generation antimicrobial agents K Juvale, A Shaik, S Kirubakaran Medchemcomm 10 (8), 1290-1301, 2019 | 21 | 2019 |
Design of inhibitors of BCRP/ABCG2 K Juvale, M Wiese Future Medicinal Chemistry 7 (12), 1521-1527, 2015 | 14 | 2015 |
Synthesis and evaluation of phenytoin derivatives as anticonvulsant agents M Deodhar, P Sable, A Bhosale, K Juvale, R Dumbare, P Sakpal Turkish Journal of Chemistry 33 (3), 367-373, 2009 | 14 | 2009 |
Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1) S Puri, K Stefan, SL Khan, J Pahnke, SM Stefan, K Juvale Journal of Medicinal Chemistry 66 (1), 657-676, 2022 | 13 | 2022 |
Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection K Juvale, G Purushothaman, V Singh, A Shaik, S Ravi, V Thiruvenkatam, ... Scientific Reports 9 (1), 190, 2019 | 11 | 2019 |
Formulation and optimization of gefitinib-loaded nanosuspension prepared using a newly developed dendritic lipopeptide oligomer material N Hegde, K Juvale, B Prabhakar Chemical Papers, 1-16, 2021 | 7 | 2021 |
Synthesis and in vitro enzymatic studies of new 3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors S Jangra, G Purushothaman, K Juvale, S Ravi, A Menon, ... Current Topics in Medicinal Chemistry 19 (5), 376-382, 2019 | 7 | 2019 |
Long circulating polymeric nanoparticles of gemcitabine HCl using PLGA-PEG-PPG-PEG block co-polymer K Kale, A Fulfager, K Juvale, KS Yadav International Journal of Polymeric Materials and Polymeric Biomaterials 73 …, 2024 | 6 | 2024 |
Facile synthesis of new N1-alkylated 1H-indazole-3-carboxamide derivatives as potential anticancer agents: In vitro, ADMET prediction, and SAR studies S Puri, K Juvale Journal of Molecular Structure 1269, 133727, 2022 | 5 | 2022 |